Why the study?
Does trimetazidine improve left ventricular function and functional status in patients with dilated ischaemic cardiomyopathy?
Does trimetazidine improve left ventricular function and functional status in patients with dilated ischaemic cardiomyopathy?
Trimetazidine added to usual therapy for 18 months improves left ventricular function, functional status, and limits the inflammatory response in patients with dilated ischaemic cardiomyopathy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
C C Shirodaria (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: